Silence, page-16

Their PR is not brilliant, but what went wrong are the results. I sure don't need to be told how far the price has dropped. Everybody is well aware of that. You seem to think we need to be constantly reminded of that, and it means little to the price going forward. Research done to date, on the other hand, is very much relevant to the chances of future success. I guess to you that is a distraction. Nobody is trying to minimize the importance of the PCH regarding trials in the USA. The PCH is NOT relevant to conducting trials in the EU or other countries. Some are trying to characterise the next announcement as almost a binary event. That being the case, if the FDA have asked for clarification on any points, then Prana should wait till discussions are complete before announcing to the market. As a holder I want that.
I don't know why Prana have not applied for a P3 in the EU as Prana indicated they would. Maybe the EMA regulators would give some weight to the fact Prana have already safely run 8 human trials with no serious safety issues.
I would like an update when the result is known. If there is a final result Prana are obligated under ASX regs to announce immediately.